Dr Dahlia Rachel Hirsch, MD in Abingdon, MD - Ophthalmology

Dr Dahlia Rachel Hirsch, MD is a Ophthalmology physician based in Abingdon, Maryland. Dr Dahlia Rachel Hirsch is licensed to practice in Maryland (license number D0020988) and her current practice location is 3913 E Baker Ave, Abingdon, Maryland. She can be reached at her office (for appointments etc.) via phone at (410) 676-9691.

NPI number for Dr Dahlia Rachel Hirsch is 1790805257 and her current mailing address is 3913 E Baker Ave, Abingdon, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1790805257.

Contact Information

	Dr Dahlia Rachel Hirsch, MD
	3913 E Baker Ave, Abingdon, MD 21009-1438
	(410) 676-9691
	Not Available

Physician's Profile

Full Name	Dr Dahlia Rachel Hirsch
Gender	Female
Speciality	Ophthalmology
Location	3913 E Baker Ave, Abingdon, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1790805257
Provider Enumeration Date: 03/29/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Dahlia Rachel Hirsch such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1790805257	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	D0020988 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Dahlia Rachel Hirsch is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Dahlia Rachel Hirsch, MD 3913 E Baker Ave, Abingdon, MD 21009-1438 Ph: (410) 676-9691	Dr Dahlia Rachel Hirsch, MD 3913 E Baker Ave, Abingdon, MD 21009-1438 Ph: (410) 676-9691

News Archive

Research reveals vital role of protein-coding gene in tumor development and immune therapy response

Researchers from the Case Comprehensive Cancer Center uncovered the potentially important role of the protein-coding gene, MYO10, in tumor development and immune therapy response. Their findings were published today in Science Advances.

An affordable, scalable and highly sensitive virus-genome-based testing approach

Aiming to reduce human suffering, economic costs, and restrictions on personal freedom caused by COVID-19 to a minimum, researchers from Germany and Austria proposed an alternative method - efficient population-based genome-based testing.

Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse

By studying a gene earlier linked to deafness in humans, researchers now have new insight into the molecular process by which components of the inner ear send messages to the brain.

Lifespan receives 2013 "Best Practice" award for improving employees' health

The New England Employee Benefits Council named Lifespan, Rhode Island's largest health system, as a recipient of the 2013 "Best Practice" award, presented annually to the companies exhibiting novel, innovative, and impactful strategies in employee benefits.

Efficacy of Guanilib confirmed for inflammatory bowel disease

Callisto Pharmaceuticals has announced additional data confirming efficacy of Guanilib, a first-in-class compound currently being developed for the treatment of inflammatory bowel disease (IBD), in two different standard animal models of experimental colitis.

Dr Dahlia Rachel Hirsch, MD - Ophthalmology in Abingdon, MD